Impact of Certain Provisions of the Revised Common Rule on FDA-Regulated Clinical Investigations: Guidance for Sponsors, Investigators, and Institutional Review Boards
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
October 11, 2018
July 18, 2019
1422bcc4-3c75-42a9-8d4e-3fae4c517eaf
Related Documents
Potency Assurance for Cellular and Gene Therapy Products
Guidance DocumentDecember 27, 2023Center for Biologics Evaluation and Research
Frequently Asked Questions — Developing Potential Cellular and Gene Therapy Products
Guidance DocumentNovember 18, 2024Center for Biologics Evaluation and Research
Submitting Study Datasets for Vaccines to the Office of Vaccines Research and Review: Guidance for Industry; Technical Specifications Document
Guidance DocumentDecember 20, 2019Center for Biologics Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox